Post hoc analysis of a phase 3, multicenter, open‐label study of cenobamate for treatment of uncontrolled focal seizures: Effects of dose adjustments of concomitant antiseizure medications
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Post hoc analysis of a phase 3, multicenter, open‐label study of cenobamate for treatment of uncontrolled focal seizures: Effects of dose adjustments of concomitant antiseizure medications
Authors
Keywords
-
Journal
EPILEPSIA
Volume 62, Issue 12, Pages 3016-3028
Publisher
Wiley
Online
2021-10-14
DOI
10.1111/epi.17092
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The ups and downs of alkyl‐carbamates in epilepsy therapy: How does cenobamate differ?
- (2021) Wolfgang Löscher et al. EPILEPSIA
- Efficacy of cenobamate for uncontrolled focal seizures: Post hoc analysis of a Phase 3, multicenter, open‐label study
- (2021) Michael R. Sperling et al. EPILEPSIA
- Cenobamate (YKP3089) as adjunctive treatment for uncontrolled focal seizures in a large, phase 3, multicenter, open‐label safety study
- (2020) Michael R. Sperling et al. EPILEPSIA
- Randomized phase 2 study of adjunctive cenobamate in patients with uncontrolled focal seizures
- (2020) Steve S. Chung et al. NEUROLOGY
- Positive allosteric modulation of GABAA receptors by a novel antiepileptic drug cenobamate
- (2020) Ramesh Sharma et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Cenobamate (XCOPRI): Can preclinical and clinical evidence provide insight into its mechanism of action?
- (2020) Michelle Guignet et al. EPILEPSIA
- Effects of cenobamate (YKP3089), a newly developed anti-epileptic drug, on voltage-gated sodium channels in rat hippocampal CA3 neurons
- (2019) Michiko Nakamura et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multicentre, double-blind, randomised, placebo-controlled, dose-response trial
- (2019) Gregory L Krauss et al. LANCET NEUROLOGY
- Treatment Outcomes in Patients With Newly Diagnosed Epilepsy Treated With Established and New Antiepileptic Drugs
- (2018) Zhibin Chen et al. JAMA Neurology
- Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy
- (2015) Alexandra L. Geffrey et al. EPILEPSIA
- Effect of reduction of antiepileptic drugs in patients with drug-refractory epilepsy
- (2015) Deepa Dash et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Antiepileptic activity of preferential inhibitors of persistent sodium current
- (2014) Lyndsey L. Anderson et al. EPILEPSIA
- Combining antiepileptic drugs—Rational polytherapy?
- (2011) Martin J. Brodie et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005-2009
- (2010) Anne T. Berg et al. EPILEPSIA
- Truly “Rational” Polytherapy: Maximizing Efficacy and Minimizing Drug Interactions, Drug Load, and Adverse Effects
- (2009) Erik St. Louis Current Neuropharmacology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now